BLLN
NASDAQ
$125.14
Billiontoone Inc - Class A (BLLN)
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company is headquartered in Menlo Park, California.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $122.14 (-2.40%)
Market Cap
$5.97B
Free Cash Flow Yield
-0.31%
Beta (5Y)
1.77
Price Chart
Valuation
Market Cap$5.97B
P/S16.85
P/B11.36
Profitability
Total Revenue (TTM)$289M
Gross Profit (TTM)$250M
EBITDA$10M
Profit Margin16.6%
Operating Margin16.5%
EPS-$0.96
Financial Health
Debt-to-Equity17.8%
Free Cash Flow Yield-0.31%
Growth & Risk
Beta (5Y)1.77
Sharpe Ratio0.62